{"id":22888,"date":"2026-05-25T04:05:45","date_gmt":"2026-05-25T04:05:45","guid":{"rendered":"https:\/\/www.europesays.com\/germany\/22888\/"},"modified":"2026-05-25T04:05:45","modified_gmt":"2026-05-25T04:05:45","slug":"how-bayer-uses-harvey-legal-ai-customers","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/germany\/22888\/","title":{"rendered":"How Bayer Uses Harvey Legal AI | Customers"},"content":{"rendered":"<p>\u201cOur ambition at Bayer \u2014 in science, business, and law \u2014 is to operate with precision, agility, and shared purpose. :Harvey: helps us deliver on that ambition in Legal by enhancing how we analyze, decide, and deliver at scale.\u201d<\/p>\n<p class=\"font-bold\">Thomas Laubert<\/p>\n<p>General Counsel<\/p>\n<p>About Bayer<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Bayer is a global leader in life sciences with a mission that defines both its business and its purpose: Health for All, Hunger for None.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Across pharmaceuticals, consumer health, and crop science, Bayer\u2019s teams are transforming how the world treats disease, cultivates food, and improves lives.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Bayer is working on breakthroughs like cell and gene therapies for Parkinson\u2019s disease, precision oncology, and hormone-free therapies to treat menopause symptoms. Behind this innovation is a company-wide transformation: a shift from traditional hierarchies to dynamic shared ownership that empowers teams to make faster decisions, innovate with agility, and shorten innovation cycles to as little as 90 days. <\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">That same transformation is now redefining how Bayer\u2019s Legal function operates.<\/p>\n<p>Opportunity<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">As Bayer accelerated its business transformation, its global legal department faced a dual challenge: complexity and scale.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Thousands of contracts, multi-jurisdictional and multilingual regulations, and research-driven intellectual property required constant review and analysis. Manual processes slowed responsiveness, while fragmented systems made it difficult to connect insights across divisions.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">\u201cOur teams were spending too much time on repetitive work \u2014 reviewing, comparing, translating,\u201d recalls Melanie K\u00fcnzel-Wieczorek, Head of Legal Chief Digital Office &amp; Contract Center. \u201cWe needed consistency, speed, and a way to share knowledge globally without reinventing it in every region.\u201d<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">The mandate from General Counsel Thomas Laubert was clear: build a unified digital backbone for Bayer Legal \u2014 one that could scale quality as quickly as the business itself.<\/p>\n<p>Solution<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Laubert\u2019s vision is taking shape through the Chief Digital Office, led by K\u00fcnzel-Wieczorek and her team. In partnership with IT, they are digitizing the full spectrum of legal work \u2014 connecting people, data, and processes through a single intelligent layer.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">A broad testing program brought together representatives from across Bayer Legal, ensuring every function \u2014 from corporate and IP to regulatory and compliance \u2014 had a voice in shaping adoption.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">\u201cAt first, people were curious but hesitant,\u201d says K\u00fcnzel-Wieczorek. \u201cToday, AI is part of our everyday rhythm. It\u2019s our second pair of eyes \u2014 helping us research, draft, and challenge our own thinking.\u201d<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Harvey is now embedded in Bayer\u2019s global legal operations \u2014 standardizing, accelerating, and connecting work across continents as part of Bayer Legal\u2019s digital transformation. Its capabilities accelerate expertise development, improve efficiency, and deliver measurable time savings in all sorts of activities that arise in a legal department \u2014 giving each member of the team back on average about three hours every week. Below are some of the key use cases where Harvey supports the Bayer Legal Department:<\/p>\n<p>Contract Review and Risk Analysis \u2014 Harvey identifies risks, suggests mitigation language, and standardizes clauses across templates, freeing lawyers for more strategic work across Confidentiality, R&amp;D (including clinical trial), M&amp;A, and Procurement contracts.<\/p>\n<p>Document Summarization and Translation \u2014 Harvey summarizes and translates long contracts and filings in minutes, improving cross-border turnaround and accuracy across multiple languages. <\/p>\n<p>Patent Drafting and Portfolio Review \u2014 Harvey helps analyze patent portfolios, draft claims, and generate claim charts, saving time and enabling deeper insight into Bayer\u2019s innovation pipeline.<\/p>\n<p>Complex Analysis &amp; Case Analysis \u2014 Vault enables rapid bulk analysis \u2014 from extracting and structuring data to summarizing facts, building chronologies, and checking contracts for key clauses.<\/p>\n<p>Contract Center Use \u2014 Connected with Bayer\u2019s global Contract Center team, Harvey supports the creation, negotiation, and maintenance of harmonized contracts \u2014 ensuring consistent terms and governance across every division.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">Harvey\u2019s flexibility and workflow integrations have made it a catalyst for digital transformation across Bayer\u2019s legal operations \u2014 matching the company\u2019s scientific precision with legal intelligence.<\/p>\n<p>Impact<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">By automating repetitive review and analysis tasks, lawyers now spend more time on complex matters, strategic risk management, and partnering with the business.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">One IP team member reported avoiding outside counsel costs by using Harvey for patent drafting and redlining. Others highlight faster turnaround on contracts and compliance summaries that once took days.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">The result is a legal function that operates with the same rigor and efficiency as Bayer\u2019s scientific divisions: precise, data-driven, and globally harmonized.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">For Laubert, the transformation is about more than productivity \u2014 it\u2019s about positioning Legal as a catalyst for innovation.<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">\u201cGenerative AI is changing how knowledge is created, shared, and applied,\u201d he explains. \u201cWith Harvey, we\u2019ve accelerated expertise development, enabling lawyers to manage increasingly complex work with confidence.\u201d<\/p>\n<p class=\"w-full mx-auto max-w-post text-secondary mb-sm text-body-1 md:leading-8\">As Bayer continues its company-wide reinvention, its legal team stands as a model for what\u2019s next: a smart, connected legal organization that scales precision, insight, and impact \u2014 at the speed of science.<\/p>\n","protected":false},"excerpt":{"rendered":"\u201cOur ambition at Bayer \u2014 in science, business, and law \u2014 is to operate with precision, agility, and&hellip;\n","protected":false},"author":2,"featured_media":22889,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21161],"tags":[21182],"class_list":["post-22888","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bayer","tag-bayer"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/22888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/comments?post=22888"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/22888\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media\/22889"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media?parent=22888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/categories?post=22888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/tags?post=22888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}